Articles

Find an Article

Filter articles

Showing 21 to 30 of 695 results

COVID-19: patent procurement and licensing

US31-03-2020Jonathan Tietz, Jason Mock, and Kristel Schorr

Jonathan Tietz, Jason Mock, and Kristel Schorr of Foley & Lardner offer their thoughts on patent procurement and licensing for COVID-19-related technologies.

UK patent system ‘no obstacle’ for ventilator production

UK19-03-2020Richard Fawcett

Richard Fawcett, senior associate at Powell Gilbert, outlines why the UK patent system poses no obstacle to the UK government’s rallying call for ventilator production amid the COVID-19 pandemic.

Broad Institute down (but not out) in the European fight over CRISPR IP

EU06-03-2020Claire Irvine

The search for clarity goes on as Broad gears up for another set of legal challenges, as Claire Irvine, partner at HGF, explains.

Global IP Exchange Europe: IP leaders’ investment priorities revealed

EU13-02-2020IQPC Exchange

Ahead of the Global IP Exchange Europe on March 9-11 in Berlin, the event’s organisers surveyed senior executives to find out their IP, patent, trademark, and brand protection investment priorities for the next 6-12 months.

Conference preview: 12th Pharma & Biotech Patent Litigation

EU, Netherlands27-01-2020

Secondary medical use case trends and research exemptions are just two issues set to be discussed at C5’s 12th Pharma & Biotech Patent Litigation meeting, on February 25–26 in Amsterdam.

Event preview: The election, Brexit, and the UPC

EU, UK25-11-2019International Quality & Productivity Center

Ahead of the IQPC - Life Science IP conference in London, Kevin Mooney, chairman of the rules and procedure committee at the UPC, answers pressing questions on the IP landscape post-Brexit and the future of the Europe-wide patents court project.

Event preview: BIO-Europe returns to Hamburg

Germany22-10-2019Anna Chrisman, EBD Group

The special 25th anniversary BIO-Europe 2019 global life science partnering event will be held November 11–13, 2019, in Hamburg, Germany.

Event preview: Life Sciences IP Due Diligence summit

US22-10-2019

The Annual Summit on Life Sciences IP Due Diligence to be held on November 14 and 15 in Boston, MA, is a one-of-a-kind, interactive forum where diligence experts discuss best practices and strategies for executing a proper IP due diligence analysis for incumbent portfolios and those of potential targets.

Medicinal cannabis: what next for Brazil?

Brazil21-10-2019Ludmila Kawakami and Ana Paula Couto

Tensions between public use, drug laws and regulators make IP around Cannabis a complex situation, explains Ludmila Kawakami and Ana Paula D. C. Couto of Di Blasi, Parente & Associados.

Conference preview: LSX World Congress USA

04-10-2019Paul Gilbertson

LSX World Congress USA brings life sciences investment and partnering to Boston.

Showing 21 to 30 of 695 results

LSIPR